Varicella-zoster virus (HHV-3)
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
The DNA virus that causes chickenpox and later reactivates as shingles (herpes zoster).
Infections
Chickenpox, shingles, herpes zoster ophthalmicus, disseminated zoster in immunocompromised patients.
Signs and symptoms
Painful band-like vesicular rash on one side of the body; rash on the forehead or nose tip suggests eye involvement.
Antibiotic and antimicrobial resistance
Resistance is rare.
Treatment considerations
Valacyclovir, famciclovir or acyclovir, ideally started early; eye involvement needs urgent ophthalmology review.
Infection control and public health
Airborne and contact precautions for chickenpox and disseminated zoster; zoster vaccination for older adults.

Sources
- CDC. Shingles (herpes zoster).
- CDC. Chickenpox (varicella).
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.